Results 71 to 80 of about 2,798 (150)

Long‐Term Outcomes of BK Viremia in Kidney Transplant Recipients

open access: yesClinical Transplantation, Volume 39, Issue 10, October 2025.
ABSTRACT Background BK viremia is associated with worse kidney transplant function and de novo donor‐specific antibodies (DSA), but mortality and graft survival are not impacted in the short‐ and intermediate‐term. The long‐term impact of BK viremia remains unclear.
Srijan Tandukar   +11 more
wiley   +1 more source

BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients

open access: yesFrontiers in Transplantation
BK polyomavirus (BKPyV) is a ubiquitous human polyomavirus and a major infection after kidney transplantation, primarily due to immunosuppression. BKPyV reactivation can manifest as viruria in 30%–40%, viremia in 10%–20%, and BK polyomavirus-associated ...
Sandesh Parajuli   +3 more
doaj   +1 more source

A Review on JC Virus Infection in Kidney Transplant Recipients

open access: yesClinical and Developmental Immunology, 2013
The polyomavirus (PyV), JC virus (JCV), is a small nonenveloped DNA virus that asymptomatically infects about 80% of healthy adults and establishes latency in the kidney tissue.
Serena Delbue   +7 more
doaj   +1 more source

Regulation of Polyomavirus Transcription by Viral and Cellular Factors

open access: yesViruses, 2020
Polyomavirus infection is widespread in the human population. This family of viruses normally maintains latent infection within the host cell but can cause a range of human pathologies, especially in immunocompromised individuals.
June F. Yang, Jianxin You
doaj   +1 more source

Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy

open access: yesClinical Transplantation, Volume 39, Issue 10, October 2025.
ABSTRACT Background Allogeneic hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT) have evolved into successful, curative treatments for many severe congenital and acquired diseases. Both use medical products of human origin and should therefore have overarching regulatory frameworks.
Hildegard T. Greinix   +14 more
wiley   +1 more source

First‐In‐Human, Randomized, Placebo‐Controlled, SAD and MAD Trial to Evaluate Safety, Tolerability, and PK/PD Modeling of Potravitug in Healthy Adults

open access: yesClinical and Translational Science, Volume 18, Issue 8, August 2025.
ABSTRACT BK polyomavirus (BKPyV) affects 10%–30% of kidney‐transplant recipients receiving immunosuppressive therapy, potentially leading to nephropathy, graft dysfunction, graft loss, and increased mortality. Despite the medical need, no targeted therapies exist.
Marcus May   +8 more
wiley   +1 more source

Polyomavirus Associated Trichodysplasia Spinulosa in a Pediatric Kidney Transplant Recipient

open access: yesPediatric Transplantation, Volume 29, Issue 5, August 2025.
ABSTRACT Background Trichodysplasia spinulosa (TS) is an inconspicuous cutaneous infection caused by a distinct polyoma virus affecting the immunocompromised host. TS is rare in children and can masquerade as other dermatological conditions, causing a delay in diagnosis.
Nivedita Pande   +7 more
wiley   +1 more source

BK and JC polyomavirus co-infection resulting in polyomavirus nephropathy and progressive multifocal leukoencephalopathy at the same time, a case report

open access: yesBrazilian Journal of Infectious Diseases
John Cunningham Virus (JCV) and BK Virus (BKV) are the most extensively studied Human Polyomaviruses (HPyVs), primarily associated with Progressive Multifocal Leukoencephalopathy (PML) and BKV Nephropathy (BKVN), respectively.
Sébastien Briol   +5 more
doaj   +1 more source

Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity

open access: yesClinical and Developmental Immunology, 2013
Polyomavirus BK-associated nephropathy (PyVAN) is the main infectious cause of allograft damage after kidney transplantation. A number of studies revealed an association between the presence of BKV-specific cellular immunity and BK viral clearance, with ...
Patrizia Comoli   +9 more
doaj   +1 more source

Late BK Nephropathy 15 years post kidney transplant following chemotherapy: A case report

open access: yesIDCases
BK Polyomavirus (BKPyV) is an important risk factor for premature graft loss following kidney transplant. Current practice guidelines recommend screening for BK virus DNA for 2 years after kidney transplant as the risk of BK Polyomavirus associated ...
Anum Hamiduzzaman   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy